Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Terminal myeloid differentiation in vivo is induced by FLT3 inhibition in FLT3/ITD AML. [electronic resource] by
- Sexauer, Amy
- Perl, Alexander
- Yang, Xiaochuan
- Borowitz, Michael
- Gocke, Christopher
- Rajkhowa, Trivikram
- Thiede, Christian
- Frattini, Mark
- Nybakken, Grant E
- Pratz, Keith
- Karp, Judith
- Smith, B Douglas
- Levis, Mark
Producer: 20130125
In:
Blood vol. 120
Availability: No items available.
|
|
15.
|
Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia. [electronic resource] by
- Maslak, Peter G
- Dao, Tao
- Krug, Lee M
- Chanel, Suzanne
- Korontsvit, Tatyana
- Zakhaleva, Victoria
- Zhang, Ronghua
- Wolchok, Jedd D
- Yuan, Jianda
- Pinilla-Ibarz, Javier
- Berman, Ellin
- Weiss, Mark
- Jurcic, Joseph
- Frattini, Mark G
- Scheinberg, David A
Producer: 20100812
In:
Blood vol. 116
Availability: No items available.
|
|
16.
|
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia. [electronic resource] by
- Pollyea, Daniel A
- Tallman, Martin S
- de Botton, Stéphane
- Kantarjian, Hagop M
- Collins, Robert
- Stein, Anthony S
- Frattini, Mark G
- Xu, Qiang
- Tosolini, Alessandra
- See, Wendy L
- MacBeth, Kyle J
- Agresta, Samuel V
- Attar, Eyal C
- DiNardo, Courtney D
- Stein, Eytan M
Producer: 20200601
In:
Leukemia vol. 33
Availability: No items available.
|
|
17.
|
Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia. [electronic resource] by
- Maslak, Peter G
- Dao, Tao
- Bernal, Yvette
- Chanel, Suzanne M
- Zhang, Rong
- Frattini, Mark
- Rosenblat, Todd
- Jurcic, Joseph G
- Brentjens, Renier J
- Arcila, Maria E
- Rampal, Raajit
- Park, Jae H
- Douer, Dan
- Katz, Laura
- Sarlis, Nicholas
- Tallman, Martin S
- Scheinberg, David A
Producer: 20190117
In:
Blood advances vol. 2
Availability: No items available.
|
|
18.
|
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study. [electronic resource] by
- DiNardo, Courtney D
- Pratz, Keith W
- Letai, Anthony
- Jonas, Brian A
- Wei, Andrew H
- Thirman, Michael
- Arellano, Martha
- Frattini, Mark G
- Kantarjian, Hagop
- Popovic, Relja
- Chyla, Brenda
- Xu, Tu
- Dunbar, Martin
- Agarwal, Suresh K
- Humerickhouse, Rod
- Mabry, Mack
- Potluri, Jalaja
- Konopleva, Marina
- Pollyea, Daniel A
Producer: 20190125
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
19.
|
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial. [electronic resource] by
- Stein, Eytan M
- Fathi, Amir T
- DiNardo, Courtney D
- Pollyea, Daniel A
- Roboz, Gail J
- Collins, Robert
- Sekeres, Mikkael A
- Stone, Richard M
- Attar, Eyal C
- Frattini, Mark G
- Tosolini, Alessandra
- Xu, Qiang
- See, Wendy L
- MacBeth, Kyle J
- de Botton, Stéphane
- Tallman, Martin S
- Kantarjian, Hagop M
Producer: 20200406
In:
The Lancet. Haematology vol. 7
Availability: No items available.
|
|
20.
|
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. [electronic resource] by
- Brentjens, Renier J
- Davila, Marco L
- Riviere, Isabelle
- Park, Jae
- Wang, Xiuyan
- Cowell, Lindsay G
- Bartido, Shirley
- Stefanski, Jolanta
- Taylor, Clare
- Olszewska, Malgorzata
- Borquez-Ojeda, Oriana
- Qu, Jinrong
- Wasielewska, Teresa
- He, Qing
- Bernal, Yvette
- Rijo, Ivelise V
- Hedvat, Cyrus
- Kobos, Rachel
- Curran, Kevin
- Steinherz, Peter
- Jurcic, Joseph
- Rosenblat, Todd
- Maslak, Peter
- Frattini, Mark
- Sadelain, Michel
Producer: 20130926
In:
Science translational medicine vol. 5
Availability: No items available.
|